Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Quality of Life, Bone Density and Safety in Postmenopausal Breast Cancer Patients With Letrozole (Femara) as an Early Adjuvant Treatment

NCT00913016 is registered in ClinicalTrials.gov with Korean Breast Cancer Study Group as lead sponsor.

NCT NCT00913016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00913016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Quality of Life, Bone Density and Safety in Postmenopausal Breast Cancer Patients With Letrozole (Femara) as an Early Adjuvant Treatment
Lead sponsor
Korean Breast Cancer Study Group
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2007
Completion date
June 30, 2012
Enrollment
897 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer